Here are three notable drugs or medical devices that have been approved by the FDA since Sept. 7:
1. Lumoxiti is an injection for the treatment of adult patients with relapse or refractory hairy cell leukemia, a rare slow-growing cancer in the blood.
2. Cassipa is a buprenorphine and naloxone sublingual film for the treatment of opioid dependence. The FDA approval provides a new dosage strength of the film.
3. Amneal Pharmaceuticals received approval for its generic version of chlorpromazine hydrochloride tablets to treat psychotic disorders or prevent and treat nausea and vomiting.